Marketing-authorisation holder · United States
Spil
2 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
2 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ASPRUZYO SPRINKLE1gm | 500mg · Granule, extended release | Ranolazine | United States | Not marketed | 2022 |
| KAPSPARGO SPRINKLE100mg tartrate | 200mg tartrate | 25mg tartrate | 50mg tartrate · Capsule, extended release | Metoprolol | United States | Marketed | 2018 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 2 | 2 | 0 | CompaniesAll medicines |
Top substances
The active substances in most of its medicines.